 | Up a level |
Begré, Lorin; Boyd, Anders; Plissonnier, Marie-Laure; Testoni, Barbara; Salazar-Vizcaya, Luisa; Suter-Riniker, Franziska; Scholtès, Caroline; Béguelin, Charles; Rockstroh, Jürgen K; Günthard, Huldrych F; Calmy, Alexandra; Cavassini, Matthias; Hirsch, Hans H; Schmid, Patrick; Bernasconi, Enos; Levrero, Massimo; Wandeler, Gilles; Zoulim, Fabien; Rauch, Andri (2024). Circulating HBV RNA and hepatitis B core-related antigen trajectories in persons with HIV/HBV coinfection and HBsAg loss on tenofovir therapy. (In Press). The journal of infectious diseases Oxford University Press 10.1093/infdis/jiae189
van Santen, Daniela K; Stewart, Ashleigh; Doyle, Joseph S; Stoové, Mark A; Asselin, Jason; Klein, Marina B; Young, Jim; Berenguer, Juan; Jarrin, Inmaculada; Lacombe, Karine; Wittkop, Linda; Leleux, Olivier; Salmon, Dominique; Bonnet, Fabrice; Rauch, Andri; Mugglin, Catrina; Matthews, Gail; Prins, Maria; Smit, Colette; Boyd, Anders; ... (2024). Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC). International journal of epidemiology, 53(1) Oxford University Press 10.1093/ije/dyad154
Begré, Lorin; Boyd, Anders; Salazar-Vizcaya, Luisa; Suter, Franziska; Béguelin, Charles; Rockstroh, Jürgen K; Günthard, Huldrych F; Calmy, Alexandra; Cavassini, Matthias; Stöckle, Marcel; Schmid, Patrick; Bernasconi, Enos; Levrero, Massimo; Zoulim, Fabien; Wandeler, Gilles; Rauch, Andri (2024). Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy. HIV medicine, 25(2), pp. 291-298. Wiley 10.1111/hiv.13561
Sacks-Davis, Rachel; van Santen, Daniela K; Boyd, Anders; Young, Jim; Stewart, Ashleigh; Doyle, Joseph S; Rauch, Andri; Mugglin, Catrina; Klein, Marina; van der Valk, Marc; Smit, Colette; Jarrin, Inmaculada; Berenguer, Juan; Lacombe, Karine; Requena, Maria-Bernarda; Wittkop, Linda; Leleux, Olivier; Bonnet, Fabrice; Salmon, Dominique; Matthews, Gail V; ... (2024). Changes in incidence of hepatitis C virus reinfection and access to direct-acting antiviral therapies in people with HIV from six countries, 2010-19: an analysis of data from a consortium of prospective cohort studies. The Lancet HIV, 11(2), e106-e116. Elsevier 10.1016/S2352-3018(23)00267-9
Trickey, Adam; Ingle, Suzanne M; Boyd, Anders; Gill, M John; Grabar, Sophie; Jarrin, Inma; Obel, Niels; Touloumi, Giota; Zangerle, Robert; Rauch, Andri; Rentsch, Christopher T; Satre, Derek D; Silverberg, Michael J; Bonnet, Fabrice; Guest, Jodie; Burkholder, Greer; Crane, Heidi; Teira, Ramon; Berenguer, Juan; Wyen, Christoph; ... (2023). Contribution of alcohol use in HIV/hepatitis C virus co-infection to all-cause and cause-specific mortality: A collaboration of cohort studies. Journal of viral hepatitis, 30(9), pp. 775-786. Blackwell Science 10.1111/jvh.13863
Isfordink, Cas J; Boyd, Anders; Sacks-Davis, Rachel; van Santen, Daniela K; Smit, Colette; Martinello, Marianne; Stoove, Mark; Berenguer, Juan; Wittkop, Linda; Klein, Marina B; Rauch, Andri; Salmon, Dominique; Lacombe, Karine; Stewart, Ashleigh; Schinkel, Janke; Doyle, Joseph S; Hellard, Margaret; van der Valk, Marc; Matthews, Gail V (2023). Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study. The lancet. Public health, 8(4), e294-e304. Elsevier 10.1016/S2468-2667(23)00056-7
van Santen, Daniela K; Sacks-Davis, Rachel; Stewart, Ashleigh; Boyd, Anders; Young, Jim; van der Valk, Marc; Smit, Colette; Rauch, Andri; Braun, Dominique L; Jarrin, Inmaculada; Berenguer, Juan; Lazarus, Jeffrey V; Lacombe, Karine; Requena, Maria-Bernarda; Wittkop, Linda; Leleux, Olivier; Salmon, Dominique; Bonnet, Fabrice; Matthews, Gail; Doyle, Joseph S; ... (2023). Treatment as prevention effect of direct-acting antivirals on primary hepatitis C virus incidence: Findings from a multinational cohort between 2010 and 2019. EClinicalMedicine, 56, p. 101810. Elsevier 10.1016/j.eclinm.2022.101810
Isfordink, Cas; Boyd, Anders; Mocroft, Amanda; Kusejko, Katharina; Smit, Colette; de Wit, Stephane; Mahungu, Tabitha; Falconer, Karolin; Wandeler, Gilles; Cavassini, Matthias; Stöckle, Marcel; Schinkel, Janke; Rauch, Andri; Peters, Lars; van der Valk, Marc (2022). Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study. Open Forum Infectious Diseases, 9(10), ofac508. Oxford University Press 10.1093/ofid/ofac508
Mocroft, Amanda; Miro, Jose M; Wandeler, Gilles; Llibre, Josep M; Boyd, Anders; van Bremen, Kathrin; Beniowski, Marek; Mikhalik, Julia; Cavassini, Matthias; Maltez, Fernando; Duvivier, Claudine; Uberti Foppa, Caterina; Knysz, Brygida; Bakowska, Elzbieta; Kuzovatova, Elena; Domingo, Pere; Zagalo, Alexandra; Viard, Jean-Paul; Degen, Olaf; Milinkovic, Ana; ... (2022). The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. HIV medicine, 23(6), pp. 585-598. Wiley 10.1111/hiv.13210
Begré, Lorin; Béguelin, Charles; Boyd, Anders; Peters, Lars; Rockstroh, Jürgen; Günthard, Huldrych F; Bernasconi, Enos; Cavassini, Matthias; Lacombe, Karine; Mocroft, Amanda; Wandeler, Gilles; Rauch, Andri (2022). Long-term trends of alanine aminotransferase levels among persons living with human immunodeficiency virus/hepatitis B virus with and without hepatitis delta coinfection. Frontiers in medicine, 9, p. 988356. Frontiers 10.3389/fmed.2022.988356
Boyd, Anders; Wandeler, Gilles (2020). Hepatitis D virus: is it all in the family? [commentary]. Gut, 69(7), pp. 1162-1163. BMJ Publishing Group 10.1136/gutjnl-2019-320549
